A prospective multicentre study may give a better estimate, although prospective community based study will be ideal.
The logistics of this national field based study will be conducted by Perspektiv, a market research company (http://perspektivred.co.uk).
More research is needed to evaluate the gut microbiota profile in CKD patients and, with the advent of high-throughput sequencing techniques like pyrosequencing, a technology that provides rapid, short-read sequencing of bases, studies will be able to better identify the bacterial phylotypes of these patients.
Large, population-based studies will be needed to identify a possible relationship of vaccination with autistic regression in persons with mitochondrial cytopathies.
In order to improve MND-based biomedical research, drug development, and clinical care, population-based studies will be important.
Similarly, research on feasible, efficient study designs, akin to current research on optimum designs for sequencing-based studies, will be needed.
Further NMR and crystallography-based studies will be required to fully characterize the ERK 1/2-dependent conformational changes in Fra-2.
For these reasons SAMs are unsuitable for practical applications as a long-term culture surface and while there is much to be learned from hPSC culture on SAMs it is currently unclear how transferrable results from SAM-based studies will be to other prospective culture surfaces.
MRI based studies will always be limited by the relatively high cost of imaging, more limited access to scanners compared to ultrasound and the relative inconvenience and tolerability of the MRI examination for patients.
